Clinical Trials Directory

Trials / Unknown

UnknownNCT04974424

Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV

Study on Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV

Status
Unknown
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
Female
Age
25 Years – 75 Years
Healthy volunteers
Accepted

Summary

Most uterine cervical high-risk human papillomavirus (HPV) infections are transient, with only a small fraction developing into cervical cancer. Family aggregation studies and heritability estimates suggest a significant inherited genetic component. Candidate gene studies and previous genome-wide association studies (GWASs) report associations between the HLA region and cervical cancer. Adopting a genome-wide approach, we aimed to establish an early warning model for a high-risk population of cervical cancer.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2021-07-23
Last updated
2021-07-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04974424. Inclusion in this directory is not an endorsement.